{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:47:18Z","timestamp":1785365238961,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.humimm.2018.05.007","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T02:50:25Z","timestamp":1527648625000},"page":"85-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["A sarcoidosis clinician\u2019s perspective of MHC functional elements outside the antigen binding site"],"prefix":"10.1016","volume":"80","author":[{"given":"Marc A.","family":"Judson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10 Pt 1","key":"10.1016\/j.humimm.2018.05.007_b0005","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.humimm.2018.05.007_b0010","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"1","key":"10.1016\/j.humimm.2018.05.007_b0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12016-014-8450-y","article-title":"The clinical features of sarcoidosis: a comprehensive review","volume":"49","author":"Judson","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.humimm.2018.05.007_b0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rmed.2016.02.011","article-title":"The three tiers of screening for sarcoidosis organ involvement","volume":"113","author":"Judson","year":"2016","journal-title":"Respir. Med."},{"issue":"8","key":"10.1016\/j.humimm.2018.05.007_b0025","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","article-title":"Sarcoidosis in America. Analysis based on health care use","volume":"13","author":"Baughman","year":"2016","journal-title":"Ann. Am. Thoracic Soc."},{"issue":"6","key":"10.1016\/j.humimm.2018.05.007_b0030","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","article-title":"Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden","volume":"48","author":"Arkema","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.humimm.2018.05.007_b0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-2007-970332","article-title":"Pathology of sarcoidosis","volume":"28","author":"Rosen","year":"2007","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.humimm.2018.05.007_b0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.12703\/P6-89","article-title":"Advances in the diagnosis and treatment of sarcoidosis","volume":"6","author":"Judson","year":"2014","journal-title":"F1000prime Rep."},{"issue":"2","key":"10.1016\/j.humimm.2018.05.007_b0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/17476348.2017.1281745","article-title":"Strategies for identifying pulmonary sarcoidosis patients at risk for severe or chronic disease","volume":"11","author":"Judson","year":"2017","journal-title":"Expert Rev. Respir. Med."},{"issue":"4","key":"10.1016\/j.humimm.2018.05.007_b0050","first-page":"231","article-title":"Mortality in sarcoidosis. A changing pattern of the causes of death","volume":"62","author":"Huang","year":"1981","journal-title":"Eur. J. Respir. Dis."},{"issue":"2","key":"10.1016\/j.humimm.2018.05.007_b0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1378\/chest.15-0615","article-title":"Histopathology of explanted lungs from patients with a diagnosis of pulmonary sarcoidosis","volume":"149","author":"Zhang","year":"2016","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.humimm.2018.05.007_b0060","first-page":"275","article-title":"Causes of death in patients with chronic sarcoidosis","volume":"33","author":"Hu","year":"2016","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"11","key":"10.1016\/j.humimm.2018.05.007_b0065","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/1744666X.2016.1196135","article-title":"Biomarkers in sarcoidosis","volume":"12","author":"Chopra","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2018.05.007_b0070","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","article-title":"A concise review of pulmonary sarcoidosis","volume":"183","author":"Baughman","year":"2011","journal-title":"Am. J. Respir. Critical Care Med."},{"issue":"4","key":"10.1016\/j.humimm.2018.05.007_b0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1165\/rcmb.2002-0164PS","article-title":"Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex?","volume":"27","author":"Moller","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.humimm.2018.05.007_b0080","first-page":"83","article-title":"HLA and sarcoidosis: new pathogenetic insights","volume":"19","author":"Martinetti","year":"2002","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.humimm.2018.05.007_b0085","first-page":"64","article-title":"Genetics","volume":"Vol 32","author":"Du Bois","year":"2005"},{"issue":"4","key":"10.1016\/j.humimm.2018.05.007_b0090","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1086\/378097","article-title":"HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites","volume":"73","author":"Rossman","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.humimm.2018.05.007_b0095","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1164\/rccm.201002-0254OC","article-title":"Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers","volume":"183","author":"Van Dyke","year":"2011","journal-title":"Am. J. Respir. Critical Care Med."},{"issue":"11","key":"10.1016\/j.humimm.2018.05.007_b0100","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/oem.2010.064220","article-title":"Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry","volume":"68","author":"Van Dyke","year":"2011","journal-title":"Occup. Environ. Med."},{"issue":"23","key":"10.1016\/j.humimm.2018.05.007_b0105","doi-asserted-by":"crossref","first-page":"12717","DOI":"10.1073\/pnas.220430797","article-title":"Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease","volume":"97","author":"Fontenot","year":"2000","journal-title":"PNAS"},{"issue":"Suppl. 5","key":"10.1016\/j.humimm.2018.05.007_b0110","first-page":"969","article-title":"Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease","volume":"104","author":"Tinkle","year":"1996","journal-title":"Environ. Health Perspect."},{"issue":"2","key":"10.1016\/j.humimm.2018.05.007_b0115","first-page":"125","article-title":"HLA and environmental interactions in sarcoidosis","volume":"25","author":"Rossman","year":"2008","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"3","key":"10.1016\/j.humimm.2018.05.007_b0120","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1183\/13993003.01791-2015","article-title":"Specific antigen(s) in sarcoidosis: a link to autoimmunity?","volume":"47","author":"Zissel","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.humimm.2018.05.007_b0125","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1164\/rccm.201407-1341OC","article-title":"Proteomic profiling reveals autoimmune targets in sarcoidosis","volume":"191","author":"Haggmark","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"13-14","key":"10.1016\/j.humimm.2018.05.007_b0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10354-014-0280-2","article-title":"Cancer, infection and disturbances of the integrity of tissue homeostasis: the most significant triggers for molecular mimicry and autoimmunity in dermatology?","volume":"164","author":"Tchernev","year":"2014","journal-title":"Wiener medizinische Wochenschrift (1946)"},{"issue":"13-14","key":"10.1016\/j.humimm.2018.05.007_b0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10354-014-0283-z","article-title":"Bacterial antigens and molecular mimicry: the bridging common problematic link in the pathogenesis of sarcoidosis and sarcoid-like reactions: isn\u2019t it time to wake up?","volume":"164","author":"Tchernev","year":"2014","journal-title":"Wiener medizinische Wochenschrift (1946)"},{"issue":"5","key":"10.1016\/j.humimm.2018.05.007_b0140","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1164\/ajrccm.164.5.2007056","article-title":"Results from a genome-wide search for predisposing genes in sarcoidosis","volume":"164","author":"Schurmann","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.humimm.2018.05.007_b0145","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1519","article-title":"Sarcoidosis is associated with a truncating splice site mutation in BTNL2","volume":"37","author":"Valentonyte","year":"2005","journal-title":"Nat Genet."},{"issue":"3","key":"10.1016\/j.humimm.2018.05.007_b0150","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1086\/444435","article-title":"The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites","volume":"77","author":"Rybicki","year":"2005","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.humimm.2018.05.007_b0155","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbadis.2006.07.006","article-title":"Sarcoidosis and NOD1 variation with impaired recognition of intracellular Propionibacterium acnes","volume":"1762","author":"Tanabe","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.humimm.2018.05.007_b0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng720","article-title":"CARD15 mutations in Blau syndrome","volume":"29","author":"Miceli-Richard","year":"2001","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.humimm.2018.05.007_b0165","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.24134","article-title":"Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis","volume":"60","author":"Okafuji","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.humimm.2018.05.007_b0170","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-3476(85)80394-2","article-title":"Familial granulomatous arthritis, iritis, and rash","volume":"107","author":"Blau","year":"1985","journal-title":"J Pediatr."},{"issue":"4","key":"10.1016\/j.humimm.2018.05.007_b0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200905-0696OC","article-title":"Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2","volume":"181","author":"Chen","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.humimm.2018.05.007_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2017.03.009","article-title":"The role of serum amyloid A staining of granulomatous tissues for the diagnosis of sarcoidosis","volume":"126","author":"Huho","year":"2017","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.humimm.2018.05.007_b0185","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2353\/ajpath.2009.080580","article-title":"FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions","volume":"174","author":"Taflin","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.humimm.2018.05.007_b0190","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JCM.40.1.198-204.2002","article-title":"Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis","volume":"40","author":"Eishi","year":"2002","journal-title":"J. Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.humimm.2018.05.007_b0195","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.20040429","article-title":"Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis","volume":"201","author":"Song","year":"2005","journal-title":"J. Experimental Med."},{"issue":"12","key":"10.1016\/j.humimm.2018.05.007_b0200","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.4049\/jimmunol.181.12.8784","article-title":"T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis","volume":"181","author":"Chen","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2018.05.007_b0205","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1128\/IAI.00732-06","article-title":"Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis","volume":"75","author":"Drake","year":"2007","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.humimm.2018.05.007_b0210","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1128\/IAI.00142-09","article-title":"Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis","volume":"77","author":"Oswald-Richter","year":"2009","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.humimm.2018.05.007_b0215","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/cei.12403","article-title":"Higher levels of interleukin IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Lofgren\u2019s syndrome","volume":"178","author":"Ostadkarampour","year":"2014","journal-title":"Clin. Experimental Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2018.05.007_b0220","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/thx.2010.140319","article-title":"Sarcoidosis is a Th1\/Th17 multisystem disorder","volume":"66","author":"Facco","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.humimm.2018.05.007_b0225","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev-pathol-011110-130318","article-title":"The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin","volume":"8","author":"Weaver","year":"2013","journal-title":"Annu. Rev. Pathol."},{"issue":"11","key":"10.1016\/j.humimm.2018.05.007_b0230","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-gamma-producing T-Helper 17.1 cells are increased in sarcoidosis and are more prevalent than T-Helper type 1 cells","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.humimm.2018.05.007_b0235","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1164\/rccm.201512-2419ED","article-title":"Sarcoidosis and T-helper cells. Th1, Th17, or Th17.1?","volume":"193","author":"Georas","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.humimm.2018.05.007_b0240","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.rdc.2015.08.012","article-title":"Corticosteroids in sarcoidosis","volume":"42","author":"Judson","year":"2016","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"5","key":"10.1016\/j.humimm.2018.05.007_b0245","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1164\/rccm.201401-0188OC","article-title":"Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity","volume":"190","author":"Braun","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.humimm.2018.05.007_b0250","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/RLU.0000000000001758","article-title":"Nivolumab-induced development of pulmonary sarcoidosis in renal cell carcinoma","volume":"42","author":"Zhang","year":"2017","journal-title":"Clin. Nucl. Med."},{"issue":"5","key":"10.1016\/j.humimm.2018.05.007_b0255","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.chest.2015.10.082","article-title":"Nivolumab-induced sarcoid-like granulomatous reaction in a patient with advanced melanoma","volume":"149","author":"Danlos","year":"2016","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.humimm.2018.05.007_b0260","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/annonc\/mdw193","article-title":"Pulmonary sarcoidosis induced by the anti-PD-1 monoclonal antibody pembrolizumab or post-immunotherapy granulomatous reaction: which is more appropriate terminology?","volume":"27","author":"Paydas","year":"2016","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.humimm.2018.05.007_b0265","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/CJI.0b013e318247a4e7","article-title":"PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer","volume":"35","author":"Dulos","year":"2012","journal-title":"J. Immunotherapy (Hagerstown, Md : 1997)"},{"key":"10.1016\/j.humimm.2018.05.007_b0270","first-page":"5","article-title":"Immunological functions of the membrane proximal region of MHC class II molecules","author":"Harton","year":"2016","journal-title":"F1000Research"},{"issue":"1","key":"10.1016\/j.humimm.2018.05.007_b0275","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1038\/s41598-018-19427-6","article-title":"Novel and haplotype specific microRNAs encoded by the major histocompatibility complex","volume":"8","author":"Clark","year":"2018","journal-title":"Scientific Rep."},{"issue":"7539","key":"10.1016\/j.humimm.2018.05.007_b0280","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13835","article-title":"Genetic and epigenetic fine mapping of causal autoimmune disease variants","volume":"518","author":"Farh","year":"2015","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.humimm.2018.05.007_b0285","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.humimm.2008.05.011","article-title":"SKDM human leukocyte antigen (HLA) tool: a comprehensive HLA and disease associations analysis software","volume":"69","author":"Kanterakis","year":"2008","journal-title":"Human Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2018.05.007_b0290","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1378\/chest.14-1099","article-title":"Obesity and weight gain in relation to incidence of sarcoidosis in US black women: data from the Black Women\u2019s Health Study","volume":"147","author":"Cozier","year":"2015","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.humimm.2018.05.007_b0295","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.06-2114","article-title":"World Trade Center \u201csarcoid-like\u201d granulomatous pulmonary disease in New York City Fire Department rescue workers","volume":"131","author":"Izbicki","year":"2007","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.humimm.2018.05.007_b0300","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1047-2797(00)00179-4","article-title":"A current assessment of rurally linked exposures as potential risk factors for sarcoidosis","volume":"11","author":"Kajdasz","year":"2001","journal-title":"Ann. Epidemiol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918301575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918301575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T22:13:45Z","timestamp":1549750425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885918301575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0198885918301575"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2018.05.007","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A sarcoidosis clinician\u2019s perspective of MHC functional elements outside the antigen binding site","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2018.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}